Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined membrane antigens. I. Reactivity in sera from normal persons and from patients with acute infectious mononucleosis
- PMID: 186222
- PMCID: PMC1541383
Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined membrane antigens. I. Reactivity in sera from normal persons and from patients with acute infectious mononucleosis
Abstract
The capacity of antibodies, directed against EBV-determined membrane antigens (MA), to induce antibody-dependent cellular cytotoxicity (ADCC) against EBV superinfected lymphoid cell lines was investigated. Such reactive antibodies were found, at high dilutions, in sera from normal EBV-positive persons but not in sera from EBV-negative persons. Sera from patients with acute infectious mononucleosis (IM), which develop EBV-specific killer T cells, did not induce ADCC. The difference in specificity between ADCC and EBV-specific killer T cells is briefly discussed.
Similar articles
-
Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined antigens. III. Reactivity in sera from patients with Burkitt's lymphoma in relation to tumour development.Clin Exp Immunol. 1977 Jul;29(1):11-5. Clin Exp Immunol. 1977. PMID: 70292 Free PMC article.
-
Relation between neutralization of Epstein-Barr virus and antibodies to cell-membrane antigens-induced by the virus.J Natl Cancer Inst. 1970 Nov;45(5):989-95. J Natl Cancer Inst. 1970. PMID: 18605425
-
Immunologic cytotoxicity against autologous human lymphocytes transformed or infected by Epstein-Bar virus: role of antibody-dependent cellular cytotoxicity in health individuals.J Natl Cancer Inst. 1980 Aug;65(2):265-71. J Natl Cancer Inst. 1980. PMID: 6249949
-
Cell-mediated immunity against Epstein-Barr virus infected B lymphocytes.Springer Semin Immunopathol. 1982;5(1):63-73. doi: 10.1007/BF00201957. Springer Semin Immunopathol. 1982. PMID: 6314570 Review. No abstract available.
-
Cellular responses to viral infection in humans: lessons from Epstein-Barr virus.Annu Rev Immunol. 2007;25:587-617. doi: 10.1146/annurev.immunol.25.022106.141553. Annu Rev Immunol. 2007. PMID: 17378764 Review.
Cited by
-
Genetics of neoplasia--impact of ecogenetics on oncogenesis. A review.Am J Pathol. 1978 Jun;91(3):609-88. Am J Pathol. 1978. PMID: 207190 Free PMC article. Review. No abstract available.
-
Progress in EBV Vaccines.Front Oncol. 2019 Feb 25;9:104. doi: 10.3389/fonc.2019.00104. eCollection 2019. Front Oncol. 2019. PMID: 30859093 Free PMC article. Review.
-
Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined antigens II. Induction of ADCC by FC-FC receptor bridging.Clin Exp Immunol. 1977 Jul;29(1):1-10. Clin Exp Immunol. 1977. PMID: 196801 Free PMC article.
-
Inhibition of Epstein-Barr virus (EBV) release from the P3HR-1 Burkitt's lymphoma cell line by a monoclonal antibody against a 200,000 dalton EBV membrane antigen.J Exp Med. 1985 May 1;161(5):1097-111. doi: 10.1084/jem.161.5.1097. J Exp Med. 1985. PMID: 2580934 Free PMC article.
-
The effects of prednisolone in leucocyte function in man. A double blind controlled study.Clin Exp Immunol. 1977 May;28(2):292-301. Clin Exp Immunol. 1977. PMID: 326447 Free PMC article. Clinical Trial.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources